Abstract Therapeutic hypothermia has been found to improve hemodynamic and metabolic parameters in cardiogenic shock. Tissue plasminogen activator (t-PA) is a pro-thrombolytic enzyme, which also possesses proinflammatory properties. Interleukin 6 (IL-6) and tumour necrosis factor alpha (TNF-a) are pro-inflammatory cytokines; interleukin 10 (IL-10) and transforming growth factor beta 1 (TGF-b1) are anti-inflammatory cytokines. The aim of this experiment was to investigate the mechanism behind the protective effect of therapeutic hypothermia in cardiogenic shock. This was done by studying the effect of hypothermia on basal t-PA levels, peripheral t-PA release, and on the inflammatory response. Cardiogenic shock was induced by inflation of an angioplasty balloon in the proximal left anterior descending artery for 40 min in 16 pigs, followed by 110 min of reperfusion. The animals were randomized to hypothermia (33°C, n = 8), or normothermia (n = 8) at reperfusion. Hemodynamic parameters were continuously monitored. Plasma was sampled every 30 min for analysis of blood-gases and t-PA, and for analysis of inflammatory markers at baseline and at the end of the experiment. t-PA, IL-6 and TGF-b1 increased during cardiogenic shock. Apart from favourably affecting hemodynamic and metabolic variables, hypothermia was found to reduce basal arterial and venous t-PA levels, and to inhibit the release of t-PA from the peripheral vascular bed. Hypothermia did not alter the inflammatory response. In conclusion, mild hypothermia improves hemodynamic and metabolic parameters in cardiogenic shock. This is associated with a reduction in basal t-PA levels and t-PA release from the peripheral vascular bed, but not with an altered inflammatory response.
Introduction
Cardiogenic shock is a major complication to acute myocardial infarction. The condition occurs in 7-10% of patients hospitalized due to myocardial infarction and is the main cause of death among these patients [1] . Despite early revascularization and circulatory support, the mortality rate remains around 50% [2] . Cardiogenic shock is a state of inadequate tissue perfusion due to cardiac dysfunction, despite adequate left ventricular filling pressure. It is caused by extensive myocardial damage and appears to be aggravated by a systemic inflammatory response [3] [4] [5] [6] . The result is hypotension with metabolic acidosis and often a fatal outcome.
Tissue plasminogen activator (t-PA) is a protease that initiates endogenous fibrinolysis in the vascular compartment via conversion of plasminogen to plasmin, and is important in controlling the coagulation process due to its thrombolytic properties. It is synthesized and stored in endothelial cells and vascular neurons [7, 8] , and is released in response to ischemia and other injurious stimuli [9] [10] [11] [12] [13] . Interestingly, t-PA has also been found to have proinflammatory properties that could contribute to tissue injury in ischemia-reperfusion injury [14, 15] .
Therapeutic hypothermia has been shown to offer tissue protection in myocardial ischemia-reperfusion injury [16, 17] . In a porcine cardiogenic shock model, mild hypothermia has been demonstrated to reduce acute mortality and metabolic acidosis, and improve hemodynamic status [18] . In an experimental setting, mild hypothermia has a positive effect on contractility, but deep hypothermia has been associated with deterioration in cardiac function [19, 20] . The tissue-protective mechanism of action is multifactorial and partly unknown [20] [21] [22] [23] [24] [25] [26] [27] . We recently found that hypothermia reduces ischemia related coronary t-PA release, suggesting a possible role for t-PA as a mechanism for reperfusion injury that may be affected by hypothermia [28] .
The primary objective of this study was to investigate the effect of therapeutic hypothermia in cardiogenic shock, on the basal levels of t-PA and on the release of t-PA from the peripheral vascular bed. The secondary objective was to investigate a possible effect on inflammation, as measured by the pro-inflammatory cytokines interleukin 6 (IL-6) and tumour necrosis factor alpha (TNF-a); and the antiinflammatory cytokines interleukin 10 (IL-10) and transforming growth factor beta 1 (TGF-b1).
Methods

Experimental preparation
Healthy domestic male and female juvenile pigs weighing 40-50 kg were fasted overnight with free access to water. The animals were premedicated with Ketaminol (Ketamine, Intervet, Danderyd, Sweden), 100 mg/ml, 0.15 ml/kg, and Rompun (Xylazin, Bayer AG, Leverkusen, Germany), 20 mg/ml, 0.1 ml/kg intramuscularly 30 min before the procedure. After induction of anesthesia with thiopental 12.5 mg/kg (Pentothal, Abbott, Stockholm, Sweden) the animals were orally intubated with cuffed endotracheal tubes. A slow infusion of 1 ml/ml fentanyl (Fentanyl, Pharmalink AB, Stockholm, Sweden) in buffered glucose (25 mg/ml) was started at a rate of 2 ml/min and adjusted if needed. During balanced anaesthesia thiopental (Pentothal, Abbott, Stockholm, Sweden) was titrated towards animal requirements with small bolus doses. Mechanical ventilation was established with a Siemens-Elema 900B ventilator in a volume-controlled mode, adjusted in order to obtain normocapnia (PCO2: 5.0-6.0 kPa). The animals were ventilated with a mixture of nitrous oxide (70%) and oxygen (30%). The pigs were continuously monitored by electrocardiography (ECG). Heparin (200 IU/kg) was given intravenously at the start of the catheterization. A 12 F introducer sheath (Boston Scientific Scimed, Maple Grove, MN, USA) was inserted into the surgically exposed left femoral vein. A 0.021-in. guide wire (Safe-T-J Curved TM , Cook Medical Inc, Bloomington, IN, USA) was inserted into the proximal inferior vena cava through the introducer. Using the guide wire, a 10.7 F Celsius Control TM catheter (Innercool Therapies Inc, San Diego, CA, USA) was placed into the inferior vena cava with the tip of the catheter at the level of the diaphragm. Body temperature was measured with a temperature probe (TYCO Healthcare Norden AB, Solna, Sweden) placed in the distal part of the esophagus. The catheter and the temperature probe were connected to the Celsius Control and the system was set to maintain a normal pig body temperature of 38.0°C. A 6 F introducer sheath (Boston Scientific Scimed, Maple Grove, MN, USA) was inserted into the surgically exposed left carotid artery upon which a 6 F FL4 Wiseguide TM (Boston Scientific Scimed, Maple Grove, MN, USA) was inserted into the left main coronary artery. The catheter was used to place a 0.014-inch PT Choice TM guide wire (Boston Scientific Scimed, Maple Grove, MN, USA) into the distal portion of the LAD. A 3.0-3.5 9 15 mm Maverick monorail TM angioplasty balloon (Boston Scientific Scimed, Maple Grove, MN, USA) was then positioned in the mid portion of the LAD, immediately distal to the first diagonal branch. A 9 F introducer sheath (Boston Scientific Scimed, Maple Grove, MN, USA) was inserted into the surgically exposed right jugular vein. A 7.5 F CCOmbo TM continuous cardiac output pulmonary artery catheter (Edwards Lifesciences, Irvine, CA, USA) was inserted into a pulmonary artery. Cardiac output was continuously recorded using a Vigilance TM monitor (Edwards Lifesciences, Irvine, CA, USA). Arterial blood pressure, pulmonary artery pressure, capillary wedge pressure and central venous pressure were continuously measured using separate transducers (ADInstruments Inc, Colorado Springs, CO, USA). Hemodynamic parameters were digitally recorded using Chart v4.2 (ADInstruments Inc, Colorado Springs, CO, USA). All radiological procedures were performed using an Opescope Pleno TM imaging system (Shimadzu Corp., Kyoto, Japan).
Experimental protocol
After a stable core body temperature of 38.0°C was established, ischemia was induced by inflation of the angioplasty balloon in the proximal LAD for 40 min, followed by 110 min of reperfusion (Fig. 1a ). An angiogram was performed after inflation of the balloon and before deflation of the balloon in order to verify total occlusion of the LAD and correct balloon positioning. After deflation of the balloon a subsequent angiogram was performed to verify restoration of blood flow in the previously occluded artery. Immediately before reperfusion the pigs were randomized to hypothermia (n = 8) or to normothermia (n = 8) (Fig. 1a) . Hypothermia was induced and maintained using the Celsius Control TM endovascular cooling system. After reaching the target temperature of 33°C, hypothermia was maintained throughout the experiment. In the normothermic group, the endovascular catheter was used to maintain a normal pig body temperature of 38°C. Pigs that died during ischemia or did not meet the criterion for cardiogenic shock (systolic blood pressure \ 90 mm Hg during at least 15 min) before randomization were excluded from the study.
Plasma samples were collected from the carotid artery and the inferior vena cava for analysis of t-PA at baseline and every 30 min until the experiment ended. Venous plasma samples were collected for analysis of IL-6, IL-10, TNF-a and TGF-b1 at baseline and at the end of the experiment. Blood gases were analyzed every 30 min throughout the experiment in an automated bench top analyzer (Radiometer Medical ApS, Brønshsøj, Denmark). The blood gas values were corrected for core body temperature at the time the samples were taken from the animals.
Biochemical analysis of t-PA and inflammatory markers
Plasma concentrations of t-PA were determined by commercial ELISA kits (TriniLIZE t-PA Antigen, Trinity Biotech, Bray, Ireland). All samples from one experiment were assayed in duplicate on the same microtest plate. The intraassay variation coefficient was 2.7%. Levels of secreted TGF-b1, TNF-a, IL-6 and IL-10 were measured by quantitative sandwich enzyme-linked antibody immunoassay technique (R&D System Europe Ltd, Abingdon, UK). Optical density was determined on a microplate reader; Spectramax Plus 384 (Molecular Devices Corporation, Sunnyvale, CA, USA).
Calculation and statistics
The net release of t-PA from the peripheral vascular bed was calculated as the difference between arterial and venous samples. Total t-PA release was calculated by factoring net t-PA release against changes in cardiac output compared to baseline (and was measured in relative units consisting of (ng/ml -ng/ml) 9 ((l/min)/(l/min)). The effects on inflammatory markers were calculated in proportion to baseline values. In order to test significance for hemodynamic, t-PA and blood gas variables, the mean value of the tested variable was calculated from the time of randomization (at reperfusion) until the end of experiment. The sample size was chosen in order to achieve a statistical power level of 0.8 for an intermediate effect size ([1.5, hence clinically relevant) on the measured parameters. Mann-Whitney's test was performed to test for differences in mean values. Linear regression was used to test for correlations. Regression analysis was performed post hoc, in an exploratory manner. Calculations and statistics were performed using the GraphPad Prism 4.0 software (GraphPad Software Inc., La Jolla, CA, USA). Statistical significance was accepted when P \ 0.05. Data are presented as mean ± SEM.
Ethics
The study conforms to the Guide for the Care and Use of Laboratory Animals, US National Institute of Health (NIH Publication No. 85-23, revised 1996) and was approved by the local animal research ethics committee. Fig. 1 Experimental protocol and temperature data. a Hypothermia was induced using an endovascular cooling catheter at reperfusion, preceded by 40 min of ischemia. Target temperature was 33.0°C and the temperature was maintained throughout the duration of the experiment. The normothermic group was maintained at a temperature of 38.0°C. b Core body temperature in the two groups. The dashed line illustrates the time of randomization and initiation of hypothermia. 45 min after initiation of hypothermia, the average temperature in the hypothermia group was 33.6°C. Error-bars denote SEM
Results
A total of 25 pigs were studied. Five pigs died prior to randomization due to intractable ventricular fibrillation or pulseless electrical activity and were excluded from the study. Four pigs were excluded due to lack of hypotension. Sixteen pigs were randomized into the two study-groups with eight animals in each group. One animal in the control group died in pulseless electrical activity 100 min from baseline.
Measurements of core body temperature are shown in Fig. 1b . At the time of initiation of ischemia and at reperfusion there was no difference in temperature between the groups. Hypothermia was induced at the time of reperfusion by the endovascular catheter. 45 min after initiation of hypothermia treatment, the mean temperature Heart rate (bpm) Fig. 2 Hemodynamic and blood-gas data. Hypothermia increased mean arterial pressure (a) and decreased heart rate (b in the hypothermia group was 33.6 ± 0.7°C. The mean cooling rate was 5.9°C/h. Detailed hemodynamic and blood-gas data are shown in Fig. 2 and Table 1 . Briefly, hypothermia resulted in an increased mean arterial pressure. Heart rate was decreased but stroke volume increased leading to a slightly increased cardiac output in the hypothermic group. Mixed venous saturation, arterial pH and base excess were higher in the hypothermic group. All these differences were statistically significant.
Detailed information on t-PA is given in Table 1 and Fig. 3 . In brief, cardiogenic shock resulted in increased basal levels of venous and arterial t-PA, as well as in netand total t-PA release (factorial correction for blood flow, see above). Hypothermia inhibited any increase in t-PA, both in basal levels and in net-and total release. All these differences were statistically significant.
There was a statistically significant inverse correlation between arterial baseline and end-experimental levels of t-PA; and mean arterial pressure, systemic vascular resistance, stroke volume, pH and mixed venous oxygen saturation. There was a strong trend towards statistical significance for an inverse correlation between arterial t-PA and cardiac output. A statistically significant positive correlation was observed for heart rate (Fig. 4) . The results for arterial values were valid also for venous values, apart It also inhibited the increase in net (c) and total (d) t-PA release. Net t-PA release was calculated as the difference between arterial samples and venous samples. Total t-PA release was calculated by factoring net t-PA release against changes in cardiac output compared to baseline. Error-bars denote SEM from cardiac output, heart rate (both clearly non-significant) and stroke volume (trend towards significance): mean arterial pressure (r 2 = 0.34, P \ 0.01), systemic vascular resistance (r 2 = 0.28, P \ 0.01), stroke volume (r 2 = 0.08, P = 0.13), pH (r 2 = 0.36, P \ 0.01), mixed venous saturation (r 2 = 0.23, P \ 0.01), cardiac output (r 2 = 0.04, P = 0.27) and heart rate (r 2 = 0.08, P = 0.12). Subgroup analysis revealed that the correlations were dependent on observations in the normothermic group (Tables 2, 3) .
Cardiogenic shock triggered a statistically significant increase in TGF-b1 and IL-6 but not in TNF-a or IL-10 at 150 min (Fig. 5) . However, there were no statistically significant differences between the hypothermic and normothermic groups in any of the measured cytokines; IL-6 (1758 ± 534 vs 3184 ± 1953 %baseline, hypothermia vs Fig. 4 Regression analysis. By linear regression analysis, the arterial baseline and endexperimental levels of t-PA were found to correlate with a mean arterial pressure, b systemic vascular resistance, c stroke volume, d heart rate, e pH, f mixed venous oxygen saturation and g base excess.
There was a trend towards statistical significance for h cardiac output normothermia, NS), IL-10 (98 ± 41 vs 132 ± 58 %base-line, hypothermia vs normothermia, NS), TNF-a (78 ± 30 vs 77 ± 24 %baseline, hypothermia vs normothermia, NS) and TGF-b1 (1063 ± 418 vs 472 ± 251 %baseline, hypothermia vs normothermia, NS) (Fig. 5 ).
Discussion
The main findings of this experiment were that cardiogenic shock resulted in increased basal levels of venous and arterial t-PA, as well as in net-and total t-PA release. Hypothermia inhibited any increase in t-PA. t-PA levels were found to correlate with both metabolic and hemodynamic parameters. Cardiogenic shock also induced an inflammatory response with increased levels of TGF-b1 and IL-6, but hypothermia did not affect this response. As reported earlier, hypothermia was found to favourably affect hemodynamic and metabolic variables [18] . The ability of hypothermia to reduce infarct size during ischemia has been demonstrated in several experimental studies [16, [29] [30] [31] [32] . However, induction of hypothermia after the onset of reperfusion does not reduce infarct size [16, 32] . In order to avoid possible bias from a reduction in infarct size, hypothermia was induced after the onset of reperfusion.
Previous experimental studies have demonstrated that mild hypothermia increases myocardial contractility in excised heart preparations as well as in the in situ heart [20, 33, 34] . The increase in contractility is considered to be mediated by an increased myofilament sensitivity to existing Ca 2? [20] , without a corresponding increase in myocardial oxygen consumption [33, 34] . A decrease in heart rate, combined with a larger stroke volume and an increased cardiac output has also been reported previously [20] . This is in line with the observations in the current experiment. Hypothermia has also been demonstrated to reduce the metabolic demand of the cells [22, 23, 35, 36] . In the current experiment, hypothermia treatment resulted in a significantly higher mixed venous saturation, pH and base excess. An explanation to the observed results could be that hypothermia lowered the peripheral oxygen demand, resulting in less tissue hypoxia and no development of metabolic acidosis. The hemodynamic and metabolic effects of hypothermia in cardiogenic shock are further discussed separately [18] .
Reduced oxygen demand does not fully explain the positive effects of hypothermia and several additive tissue protective effects have been suggested [24] . It has been shown that mild hypothermia can prevent ischemic cells from entering apoptosis through prevention of mitochondrial dysfunction and inhibition of caspase release [25] [26] [27] . Moreover, hypothermia has been shown to improve ion homeostasis, decrease free radical formation, stabilize cellular membranes and prevent intracellular acidosis [21] . It has also been shown to reduce ischemia related coronary t-PA release [28] . In the current experiment hypothermia was found to inhibit a shock-related increase in basal arterial and venous levels of t-PA and also the release of t-PA from the peripheral vascular bed.
The release of t-PA is triggered by various injurious stimuli including ischemia, and is mediated by a variety of substances including thrombin, ADP, serotonin, bradykinin, and epinephrine [9] [10] [11] [12] [13] [37] [38] [39] [40] [41] . It is possible that the release of t-PA was triggered by the shock related metabolic compromise. This hypothesis is supported by the observed inverse correlations between pH, base excess, mixed venous saturation and t-PA. However, even though the hypothermic animals were less metabolically compromised, they were still in shock and not metabolically unaffected. As hypothermia completely abolished t-PA release above basal levels, a more selective effect on the endothelial t-PA release is indicated. This hypothesis is further supported by the fact that significant correlations between t-PA and metabolic parameters were confined to the normothermic group. Although t-PA is important in keeping vessel walls free from thrombi under physiologic circumstances, it has been found to have proinflammatory properties that could contribute to reperfusion injury [14, 15, 42, 43] . In this experiment, cardiogenic shock was found to increase the anti-inflammatory TGF-b1 and pro-inflammatory IL-6, to a similar degree in both groups. The effect of shock on the pro-inflammatory TNF-a and anti-inflammatory IL-10 was neutral in both groups. Thus, a possible positive effect of t-PA on hemodynamic parameters does not involve these cytokines. However, t-PA has been reported to activate inducible nitric oxide synthase (iNOS) [44] , which acts to increase the levels of nitric oxide (NO). In turn, NO has been associated with a reduction in myocardial contractility by uncoupling of calcium metabolism [45, 46] , through effects on glucose metabolism [46] , and through a reduction in b-adrenergic responsiveness [47] . Furthermore, NO induce vasodilatation, thereby decreasing coronary perfusion pressure and systemic perfusion [3] . Mild hypothermia has been demonstrated to reduce iNOS [48, 49] . In the current experiment, there was an inverse correlation between t-PA and systemic vascular resistance, mean arterial pressure and stroke volume. Possibly, the reduction in t-PA is a contributing link between hypothermia and improved hemodynamic status, via reduced iNOS levels. As judged by the analysis of correlations between t-PA and hemodynamic parameters, the effect attributable to such a mechanism appear to be mild to moderate in magnitude. Further research is warranted to test this hypothesis.
Limitations
In an experimental model with hemodynamic compromise and temperature related influence on the circulation, changes in hepatic blood flow may arise. By sampling venous blood in the inferior vena cava, there may be influence of changes in hepatic clearance on venous t-PA levels.
Conclusion
Mild hypothermia improves hemodynamic and metabolic parameters in cardiogenic shock. This is associated with a reduction in basal t-PA levels and t-PA release from the peripheral vascular bed, but not with an altered There were no statistically significant differences between the hypothermic and normothermic groups. Please note that the scale on the y-axis differ between the graphs. Error-bars denote SEM inflammatory response as measured by IL-6, IL-10, TNF-a and TGF-b1.
